Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-003445
Filing Date
2017-03-06
Accepted
2017-03-06 13:58:31
Documents
44
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q crxm-10q_20160630.htm 10-Q 750208
2 EX-31.1 crxm-ex311_12.htm EX-31.1 10675
3 EX-31.2 crxm-ex312_11.htm EX-31.2 10557
4 EX-32 crxm-ex32_10.htm EX-32 5920
  Complete submission text file 0001564590-17-003445.txt   3250062

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT crxm-20160630.xml EX-101.INS 453353
6 XBRL TAXONOMY EXTENSION SCHEMA crxm-20160630.xsd EX-101.SCH 36795
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crxm-20160630_cal.xml EX-101.CAL 22925
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crxm-20160630_def.xml EX-101.DEF 147943
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE crxm-20160630_lab.xml EX-101.LAB 272054
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crxm-20160630_pre.xml EX-101.PRE 224443
Mailing Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121
Business Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121 (858) 436-1000
Taxus Cardium Pharmaceuticals Group Inc. (Filer) CIK: 0000772320 (see all company filings)

EIN.: 840635673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33635 | Film No.: 17667369
SIC: 2836 Biological Products, (No Diagnostic Substances)